Results 101 to 110 of about 1,783,253 (264)

Opsoclonus in Pediatric Patients: Differential Diagnosis and a Practical Approach to Evaluation

open access: yesAnnals of the Child Neurology Society, EarlyView.
ABSTRACT Opsoclonus is an ocular dyskinesia characterized by involuntary, arrhythmic, multidirectional saccades. In pediatrics, opsoclonus is most commonly attributed to the rare neuroinflammatory disorder opsoclonus‐myoclonus‐ataxia syndrome (OMAS), typically considered a paraneoplastic syndrome associated with neural crest tumors. However, opsoclonus
Aubrey C. Reed   +5 more
wiley   +1 more source

Clinical Model‐Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Traditional dosing strategies often rely on a “one‐size‐fits‐all” paradigm, assuming an “average” patient with typical demographic and pharmacological characteristics. In reality, this often overlooks existing between‐patient variability and can lead to suboptimal drug exposure or toxicity. This issue is especially pronounced in pediatric patients, who
Zachary L. Taylor   +12 more
wiley   +1 more source

Identification of patients with moderate medically unexplained physical symptoms in primary care with a five years follow-up

open access: yesBMC Family Practice, 2019
Background Patients with medically unexplained physical symptoms (MUPS) are common in primary care, with a spectrum from mild to moderate and chronic MUPS.
Paula Elisabeth van Westrienen   +3 more
doaj   +1 more source

Medically unexplained symptoms and syndromes [PDF]

open access: yesClinical Medicine, 2002
Simon Wessley   +2 more
openaire   +3 more sources

Medically unexplained visual symptoms in children and adolescents: an indicator of abuse or adversity?

open access: yes
Purpose To highlight abuse and adversity in childhood as an association of medically unexplained symptoms. Methods Case series. Results Two young adults and one child (all female) are described with medically unexplained impaired vision and diplopia ...
Clarke MP, Porteous AM
core   +5 more sources

UMOD Genotype and Clinical Outcomes in Heart Failure Patients Treated with Loop Diuretics: A UK Biobank Pharmacogenetic Cohort Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Uromodulin (UMOD) regulates tubular sodium handling and modulates NKCC2, the molecular target of loop diuretics (LD). Although UMOD variants have been associated with blood pressure and hypertension, their pharmacogenetic relevance in heart failure (HF) remains unknown.
Reinhold Kreutz   +5 more
wiley   +1 more source

A scoping review of treatment for factitious disorder (imposed on self)

open access: yesPsychiatry Research Communications
Introduction: Factitious disorder imposed on self (FDIS) has a deleterious impact on sufferers through the sequalae of induced illness as well as the consequences of unnecessary investigations and treatments.
Rose Kong Liu   +2 more
doaj   +1 more source

Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms [PDF]

open access: yes, 2007
Background: Reattribution is frequently taught to general practitioners (GPs) as a structured consultation that provides a psychological explanation for medically unexplained symptoms. Aims: To determine if practice-based training of GPs in reattribution
Dunn, Graham   +11 more
core   +1 more source

Model‐Informed Approaches for Pediatric Type 2 Diabetes Evidence Generation: Insights from a Model‐Based Longitudinal HbA1c Meta‐Analysis from EMA Marketing Authorization Applications

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Evidence generation for antihyperglycemic therapies in pediatric type 2 diabetes mellitus (T2DM) remains challenging, with most randomized trials failing to demonstrate statistically significant reductions in glycated hemoglobin (HbA1c), partly due to substantial between‐subject variability.
Pieter J. Colin   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy